BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35654004)

  • 21. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
    Kornegoor R; Moelans CB; Verschuur-Maes AH; Hogenes MCh; de Bruin PC; Oudejans JJ; van Diest PJ
    Breast Cancer Res; 2012 Jul; 14(4):R101. PubMed ID: 22765268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer.
    Papadopoulou E; Davilas E; Sotiriou V; Georgakopoulos E; Georgakopoulou S; Koliopanos A; Aggelakis F; Dardoufas K; Agnanti NJ; Karydas I; Nasioulas G
    Ann N Y Acad Sci; 2006 Sep; 1075():235-43. PubMed ID: 17108217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.
    Sierra-Ramirez JA; Seseña-Mendez E; Godinez-Victoria M; Hernandez-Caballero ME
    Adv Clin Exp Med; 2021 May; 30(5):507-515. PubMed ID: 33847474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and epigenetic modifications of adiponectin gene: Potential association with breast cancer risk.
    Pasha HF; Mohamed RH; Toam MM; Yehia AM
    J Gene Med; 2019 Oct; 21(10):e3120. PubMed ID: 31415715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
    Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
    Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cohesin occupancy and composition at enhancers and promoters are linked to DNA replication origin proximity in
    Pherson M; Misulovin Z; Gause M; Dorsett D
    Genome Res; 2019 Apr; 29(4):602-612. PubMed ID: 30796039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas.
    Deb S; Xu H; Tuynman J; George J; Yan Y; Li J; Ward RL; Mortensen N; Hawkins NJ; McKay MJ; Ramsay RG; Fox SB
    Br J Cancer; 2014 Mar; 110(6):1606-13. PubMed ID: 24548858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.
    Yun J; Song SH; Kim HP; Han SW; Yi EC; Kim TY
    EMBO Rep; 2016 Sep; 17(9):1343-59. PubMed ID: 27466323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation and breast cancer: A way forward (Review).
    Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.
    Atienza JM; Roth RB; Rosette C; Smylie KJ; Kammerer S; Rehbock J; Ekblom J; Denissenko MF
    Mol Cancer Ther; 2005 Mar; 4(3):361-8. PubMed ID: 15767545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
    Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
    Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary parabens and breast cancer risk: Modification by LINE-1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status.
    Parada H; Sahrai L; Wolff MS; Santella RM; Chen J; Neugut AI; Teitelbaum SL
    Mol Carcinog; 2022 Nov; 61(11):1002-1015. PubMed ID: 35975911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
    Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
    Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.
    Huang YT; Li FF; Ke C; Li Z; Li ZT; Zou XF; Zheng XX; Chen YP; Zhang H
    J Transl Med; 2013 Oct; 11():245. PubMed ID: 24090193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
    Kon A; Shih LY; Minamino M; Sanada M; Shiraishi Y; Nagata Y; Yoshida K; Okuno Y; Bando M; Nakato R; Ishikawa S; Sato-Otsubo A; Nagae G; Nishimoto A; Haferlach C; Nowak D; Sato Y; Alpermann T; Nagasaki M; Shimamura T; Tanaka H; Chiba K; Yamamoto R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Nakamaki T; Ishiyama K; Nolte F; Hofmann WK; Miyawaki S; Chiba S; Mori H; Nakauchi H; Koeffler HP; Aburatani H; Haferlach T; Shirahige K; Miyano S; Ogawa S
    Nat Genet; 2013 Oct; 45(10):1232-7. PubMed ID: 23955599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calpain-1 cleaves Rad21 to promote sister chromatid separation.
    Panigrahi AK; Zhang N; Mao Q; Pati D
    Mol Cell Biol; 2011 Nov; 31(21):4335-47. PubMed ID: 21876002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.